Literature DB >> 2826163

Omega-oxidation of cysteine-containing leukotrienes by rat-liver microsomes. Isolation and characterization of omega-hydroxy and omega-carboxy metabolites of leukotriene E4 and N-acetylleukotriene E4.

L Orning1.   

Abstract

Leukotriene E4 was metabolized to two polar products by rat liver microsomes. These products were characterized by physico-chemical and chemical techniques. The chemical structures, (5S, 6R)-5,20-dihydroxy-6S-cysteinyl-7,9-trans-11,14-cis-icosatetraenoic acid (omega-hydroxy-leukotriene E4) and (5S, 6R)-5-hydroxy-6S-cysteinyl-7,9-trans-11,14-cis-icosatetraen-1,20-d ioic acid (omega-carboxy-leukotriene E4) suggested that leukotriene E4 was transformed by an omega-hydroxylase and omega-hydroxyleukotriene E dehydrogenase in sequence. N-Acetyl-leukotriene E4 was also transformed by these enzymes, but at a rate six times lower than leukotriene E4. The products formed from N-acetylleukotriene E4 were characterized as being N-acetyl-omega-hydroxy-leukotriene E4 and N-acetyl-omega-carboxy-leukotriene E4. Other substrates were 11-trans-leukotriene E4 and N-acetyl-11-trans-leukotriene E4. In contrast, leukotrienes C4 and D4 were not converted into omega-oxidized metabolites. The leukotriene E omega-hydroxylase reaction required NADPH and molecular oxygen as cofactors, and was most rapidly catalyzed by liver microsomes. Liver cytosol, fortified with NAD+, converted omega-hydroxyleukotriene E4 and N-acetyl-omega-hydroxy-leukotriene E4 into omega-carboxy metabolites. Microsomes contained at least 18 times less omega-hydroxy-leukotriene E dehydrogenase activity than did cytosol. Liver microsomes supplemented with acetyl-coenzyme A converted omega-hydroxy and omega-carboxy-leukotriene E4 into the corresponding N-acetyl derivatives. The novel enzyme, leukotriene E omega-hydroxylase, which is described here is distinct from a previously described leukotriene B omega-hydroxylase based on substrate competition and kinetic data.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2826163     DOI: 10.1111/j.1432-1033.1987.tb13669.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  8 in total

Review 1.  [The Heinrich-Wieland Prize presentation. Metabolism and analysis of leukotrienes in vivo].

Authors:  D Keppler
Journal:  Klin Wochenschr       Date:  1988-10-17

2.  Hepatic uptake and metabolic disposition of leukotriene B4 in rats.

Authors:  W Hagmann; M Korte
Journal:  Biochem J       Date:  1990-04-15       Impact factor: 3.857

3.  Uptake, production and metabolism of cysteinyl leukotrienes in the isolated perfused rat liver. Inhibition of leukotriene uptake by cyclosporine.

Authors:  W Hagmann; S Parthé; I Kaiser
Journal:  Biochem J       Date:  1989-07-15       Impact factor: 3.857

4.  Impaired degradation of leukotrienes in patients with peroxisome deficiency disorders.

Authors:  E Mayatepek; W D Lehmann; J Fauler; D Tsikas; J C Frölich; R B Schutgens; R J Wanders; D Keppler
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

5.  Effect of the leukotriene receptor antagonists FPL 55712, LY 163443, and MK-571 on the elimination of cysteinyl leukotrienes in the rat.

Authors:  C Denzlinger; M Grimberg; A Kapp; C Haberl; W Wilmanns
Journal:  Br J Pharmacol       Date:  1991-04       Impact factor: 8.739

Review 6.  Cytochrome P450 ω-Hydroxylases in Inflammation and Cancer.

Authors:  Amanda L Johnson; Katheryne Z Edson; Rheem A Totah; Allan E Rettie
Journal:  Adv Pharmacol       Date:  2015-06-27

7.  Metabolomics analysis of maternal serum exposed to high air pollution during pregnancy and risk of autism spectrum disorder in offspring.

Authors:  Ja Hyeong Kim; Qi Yan; Karan Uppal; Xin Cui; Chenxiao Ling; Douglas I Walker; Julia E Heck; Ondine S von Ehrenstein; Dean P Jones; Beate Ritz
Journal:  Environ Res       Date:  2021-02-04       Impact factor: 8.431

Review 8.  Unraveling the genetic basis of aspirin hypersensitivity in asthma beyond arachidonate pathways.

Authors:  Se-Min Park; Jong Sook Park; Hae-Sim Park; Choon-Sik Park
Journal:  Allergy Asthma Immunol Res       Date:  2013-05-27       Impact factor: 5.764

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.